We are live on
!
Find out more
WT
Wellcome Trust Portfolio holdings
AUM
$9.01B
1-Year Est. Return
12.05%
This Fund
S&P 500
This Quarter
Est. Return
+4.62%
1 Year Est. Return
+12.05%
3 Year Est. Return
+59.66%
5 Year Est. Return
+58.12%
10 Year Est. Return
+403.84%
AUM
$6.33B
AUM Growth
+$92.4M
(+1.5%)
Cap. Flow
-$69.9M
Cap. Flow
% of AUM
-1.1%
Top 10 Holdings %
Top 10 Hldgs %
76.06%
Holding
21
New
–
Increased
4
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$45M |
| 2 |
Alibaba
BABA
|
+$13.7M |
| 3 |
Itaú Unibanco
ITUB
|
+$8.62M |
| 4 |
JD.com
JD
|
+$2.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$81.8M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$57.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.41% |
| 2 | Technology | 29.51% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Communication Services | 10.99% |
| 5 | Consumer Staples | 5.68% |
Similar funds
A
VAS
AI
AI
HI
SFM
MIH
RWP
Wellcome Trust's Q3 2018 Portfolio in Review
As of Q3 2018, Wellcome Trust held 21 positions worth $6.33B, up 1.5% from $6.23B the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Trading was light in Q3 2018: portfolio turnover was 4.8%. Wellcome Trust opened no new positions and exited 1, leaving the 21-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
- Wellcome Trust added most to GE Aerospace in Q3 2018, an estimated $45M increase.
- Wellcome Trust's biggest Q3 2018 reduction was Procter & Gamble, cutting an estimated $81.8M.
- Wellcome Trust fully exited iShares Core MSCI Emerging Markets ETF in Q3 2018, selling an estimated $57.8M.
- Wellcome Trust's ten largest holdings make up 76% of its $6.33B portfolio in Q3 2018.
- Wellcome Trust opened 0 new positions and closed 1 in Q3 2018.
- Wellcome Trust's portfolio value rose 1.5% quarter-over-quarter to $6.33B.
Based on Wellcome Trust's 13F filing for Q3 2018, filed 29 Oct 2018.